Pathological effects of diabetic mice with Helicobacter pylori infection

Read full text
Authors: Wan-Ping Yang, Jin-Hai Zeng, Biao-Liang Wu, Wen-Ting Zhou, Jia-Zi Luo, Yuan-Yuan Dai, Shi-Xian Yang, Zan-Song Huang, Yan-Qiang Huang
Cited by: 2
References: 25

Abstract

BACKGROUND Helicobacter pylori (H. pylori ) is widely present in the human gastric mucosa and is closely associated with a variety of gastric diseases. Recent studies have found that H. pylori infection is closely associated with diabetic patients and may adversely affect their glucose metabolism and organ function. However, the effect of H. pylori infection on pathological changes in the body during a diabetic state remains unclear. AIM To investigate the effects of H. pylori infection on the physiology and pathological changes in the organs of diabetic mice. METHODS The diabetic mice models were established using streptozotocin (STZ). The mice were infected with H. pylori through oral gavage, with their fasting blood glucose (FBG) and body weight monitored dynamically over a period of 1 to 13 months after infection. Pathological changes in major organs (including the pancreas, stomach, liver, and kidneys) were assessed, along with apoptosis levels in these tissues. The expression of H. pylori virulence factors in the liver and alterations in the intestinal microbiota were also analyzed. RESULTS H. pylori infection led to significant fluctuations in FBG in diabetic mice from the 1st to 9th month, with FBG levels remaining consistently elevated. Body weight increased gradually but remained significantly lower than that of both uninfected diabetic mice and non-diabetic controls. Pancreatic islet cell numbers decreased, accompanied by persistent inflammation and tissue damage for over 9 months. H. pylori colonized the stomach for at least 7 months, causing irreversible gastric mucosal inflammation; by the 13th month, diffuse dense inflammatory infiltration occupying the entire submucosal layer was observed. Progressive damage was observed in liver and kidney tissues, with marked expression of H. pylori virulence factors in the liver by the 9th month. Additionally, significant gut microbiota dysbiosis was observed. CONCLUSION The STZ-induced diabetic mouse model with H. pylori infection can significantly prolong the colonization time of H. pylori in the stomach and exacerbate the degree of damage to the stomach, liver, and kidney organs.

Fields of Study & Subjects

Helicobacter pylori-related gastroenterology studies Diabetes Treatment and Management Gastric Cancer Management and Outcomes

Publication details

Journal / source
World Journal of Diabetes
Publisher
Baishideng Publishing Group Inc.
Volume
17
Issue
2
Pages
112534–112534
Publication date
6 February 2026
Language
EN